HETERO LABS LIMITED - India is a pharmaceuticals company based out of India.

HETERO LABS LIMITED - India

Human Resources Officer

General Manager

QA Deputy General Manager

Quality Assurance Manager

Assistant Manager

Chemist

Trainee research associate

Project Trainee

Process Engineer

Sr.operator

HVAC and water system

Team Manager

General Manager-Corporate Quality Assurance

Assistant General Manager - Corporate Quality Assurance

Manager-QA & RA

Assistant Manager-Quality Assurance

Analytical Chemist

Senior Chemist

Assistant Manager in Quality Control

GoDaddy Hosting

Apache

Mobile Friendly

Bootstrap Framework

YouTube

Google Font API

Welcome to Eisai India. Eisai (pronounced 'ā-zī') is derived from the Japanese word for 'health product' and, here at Eisai, we discover, develop and market innovative, high quality medicines throughout the world. Eisai is one of the world's leading research-based pharmaceutical companies. With operations in the U.S., Asia, Europe, Russia, India, Africa, the Middle East, Australia and it's domestic home market of Japan, Eisai employs more than 11,000 people worldwide.Eisai Pharmaceuticals India Pvt. Ltd. (Eisai India) was incorporated in October 2004, with registered office at Mumbai. Eisai Co.,Ltd was the first Japanese company to have a 100% subsidiary in Indian pharmaceutical market.Eisai India product portfolio includes prescription medicines in several therapeutic areas such as central nervous system disorders, metastatic breast cancer, benign prostrate hyperplasia , muscle spasm, vertigo, gastrointestinal disorders, diabetes and peripheral neuropathy.Eisai India has a dedicated team of well-trained 200 field force across the country under various specialties and more than 250 employees across Research and Manufacturing. We continuously work with Medical Doctors and the Healthcare professionals in India to ensure that they have updated information on our products so that they can prescribe the best products for the health care needs of their patients. Eisai India's integrated Manufacturing and Research facility at Visakhapatnam (Vizag), Andhra Pradesh stimulates knowledge creation between teams – from those who create products through research, to those who produce - by bringing them together on one site and is supplemented by  the necessary support functions.Eisai India's Vizag facility manufactures Drug Substances (Active Pharmaceutical Ingredients-APIs), Drug Products (Oral solid dosage forms-Tablets) and carries out Developmental Research of Active Pharmaceutical Ingredients (APIs).This facility is registered as a pharmaceutical manufacturer at regulatory agencies viz USFDA, PMDA, MHRA and WHO. Research labs at Vizag facility are recognized by the Department of scientific and industrial research (DSIR). Facility also received the Certification of ISO 14001:2004 for Environment management system (EMS), OHSAS 18001 for Occupational Health and Safety Series and ISO 27001 for Information security management system from TUV SUD.

Eisai Pharmaceuticals India

Outlook

Microsoft Office 365

Lupin is the U.S. wholly-owned subsidiary of Lupin Limited, which is among the top pharmaceutical companies in India. Through our sales and marketing headquarters in Baltimore, MD Lupin is dedicated to delivering high-quality, branded and generic medications trusted by healthcare professionals and patients across geographies.

Senior Director- US IT

Director, Portfolio Management

Facilities Engineering Specialist

Manager Operational Excellence

Lupin Pharmaceuticals

Microsoft Azure Hosting

Ranbaxy Laboratories Limited, India's largest pharmaceutical company, is an integrated, research based, international pharmaceutical company, producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies. Ranked 8th amongst the global generic pharmaceutical companies, Ranbaxy today has a presence in 23 of the top 25 pharmaceutical markets of the world. The Company has a global footprint in 49 countries, world-class manufacturing facilities in 11 countries and serves customers in over 125 countries.In June 2008, Ranbaxy entered into an alliance with one of the largest Japanese innovator companies, Daiichi Sankyo Company Ltd., to create an innovator and generic pharmaceutical powerhouse. The combined entity now ranks among the top 15 pharmaceutical companies, globally. The transformational deal will place Ranbaxy in a higher growth trajectory and it will emerge stronger in terms of its global reach and in its capabilities in drug development and manufacturing. Vision & AspirationsRanbaxy is driven by its vision to achieve significant business in proprietary prescription products by 2012 with a strong presence in developed markets. The Company aspires to be amongst the Top 5 global generic players and aims at achieving global sales of US $5 Bn by 2012.FinancialsRanbaxy was incorporated in 1961 and went public in 1973. For the year 2008, the Company recorded Global Sales of US $ 1,682 Mn, reflecting a growth of 4%. The Company has a balanced mix of revenues from emerging and developed markets that contribute 54% and 39% respectively. In 2008, North America, the Company's largest market contributed sales of US $ 449 Mn, followed by Europe garnering US $ 330 Mn. Business in Asia has been going strong with India clocking sales of around US $ 300 Mn with market leadership in several business segments, backed by strong brand-building skills.

Ranbaxy

Cloudflare DNS

CloudFlare Hosting

Dr.Reddy's is an India-based pharmaceutical company that manufactures and markets medicines, active pharmaceutical ingredients and intermediates for for the healthcare sector.

Director / Group Controller, BD & M&A

Director / Lead, Business Development

Dr. Reddy's Laboratories

Route 53

Google Cloud Hosting

Pardot

Amazon SES

Established in Hyderabad, India in 1978, Gland Pharma is one of the fastest-growing small-molecule generic injectables-focused company, with a global footprint across 60 countries, including the United States, Europe, Canada, Australia, India and other markets in the rest of the world. Gland Pharma has seven manufacturing facilities in India, comprising four facilities for finished formulations and three API facilities. We are focused on meeting diverse injectables needs with a stable supply of affordable and high-quality products. We have established a portfolio of injectables products across various therapeutic segments and delivery systems and are present in sterile injectables, oncology and ophthalmics with a focus on complex injectables.

Abburi Naresh

General Manager at HETERO LABS LIMITED - India

Abburi Naresh's Professional Contact Details

Abburi Naresh's Current Company Details

HETERO LABS LIMITED - India

Abburi Naresh's Work History and Education

Others Named Abburi Naresh

Frequently Asked Questions about Abburi Naresh

What company does Abburi Naresh work for?

What is Abburi Naresh's role at HETERO LABS LIMITED - India?

What is Abburi Naresh's email address?

What is Abburi Naresh's business email address?

What is Abburi Naresh's HQ phone number?

What industry does Abburi Naresh work in?

Who are Abburi Naresh's colleagues?

Colleagues at HETERO LABS LIMITED - India

Prospect on LinkedIn

People Search

Company Search

Erik Straub

Michael Transon

Ready to try it out?